Use of HIRREM, a closed-loop, allostatic, acoustic, stimulation neurotechnology can reduce PTSD symptoms, insomnia and depression in veterans.
For adults with bipolar depression, tDCS seems to be safe and effective as an add-on intervention.
Depression is one of the most commonly reported complications resulting from stroke.
Paternal use of SSRIs before conception is linked to an increased risk of ADHD in offspring.
No overall difference in terms of total brain volume or total gray and white matter volume for children with ADHD and control subjects was observed.
Nonoptimal infant neuromotor development was linked to genetic risk for schizophrenia, but not bipolar disorder.
Brexanolone was well tolerated among study participants.
There is an increased relative risk of preclampsia linked with psychostimulant use while pregnant.
Frequency of migraine with or without aura may be correlated with symptoms of anxiety and depression.
The FDA has cleared Nexstim's NBT system for the treatment of major depressive disorder.
There is an increased risk of neonatal morbidity associated with exposure to ADHD medication in utero.
Specific inflammatory biomarkers may have an impact on the risk of developing schizophrenia.
For patients with comorbid depression and TBI, NILT is effective in bringing remission.
Given the prevalence of depression in Parkinson's disease and the effectiveness of antidepressants, health care providers should promote adherence in clinical practice.
Incidence of neuroleptic malignant syndrome, akathisia, and parkinsonism was higher in the ID group.
A panel of clinicians from different pediatric fields have developed new guidelines for the treatment of PANS.
Youth who have bipolar disorder are not affected by a decline in cognitive function into adulthood.
The findings suggest the importance of screening for posttraumatic stress disorder in this population.
Previous research has found a higher prevalence of depression before and after an epilepsy diagnosis.
Escitalopram may be better for the treatment of depression than tDCS.
The longer women are exposed to estrogen during reproductive years, the less likely they are to be depressed.
Patients who take medication for ADHD may have a lower risk of developing a substance abuse disorder.
Treatment with psychotropic medications may influence dementia risk in veterans with posttraumatic stress disorder.
Poor adherence to antipsychotic treatment in schizophrenia may be attributable to socially negative representations of schizophrenia.
Overall, depression affects significantly more women than men.
Patients with schizophrenia, schizoaffective disorder, and psychotic bipolar disorder were examined for anticholinergic burden.
Veterans with comorbid PTSD and dementia were more likely to be prescribed second-generation antipsychotics.
Underlying pathophysiological mechanisms may connect depression and epilepsy.
Prescriptions for benzodiazepine lasting 2-3 months or more and marked dose increases should be avoided.
A study aimed to clarify the relationship between anxiety and depression in patients with multiple sclerosis.
Neurology Advisor Articles
- Clarifying Cardiovascular Risk in Migraine
- Parkinson Disease Symptom Fluctuations Well-Managed With Adaptive Deep Brain Stimulation
- More Evidence Supports Benefits of Cannabidiol for Treatment-Resistant Epilepsy
- Monthly Erenumab Reduces Frequency of Episodic Migraine
- Reduced Risk for Multiple Sclerosis Linked to Greater Sun Exposure
- Tamsulosin Associated With Dementia Risk in Older Patients With BPH
- FDA Approves Blood Test to Assess Concussion
- Gait Difficulty in Parkinson Disease May Be Associated With More Progressive Disease Course
- Tau PET a Useful Biomarker for Alzheimer Disease Risk and Progression
- Multiple Sclerosis Drug Zinbryta Withdrawn From the Market
- Incidence of Delayed Traumatic Intracranial Hemorrhage Low in Older Adults With Blunt Head Trauma
- Older Epilepsy Patients More Likely to Experience AED, Non-AED Drug Interaction
- Female Gender, Natalizumab Exposure Associated With Increased Lymphopenia Risk in FNG-Treated MS
- Accelerated Cognitive Decline Associated With Retinopathy
- Treatment Effects Often Exaggerated in Early Clinical Studies